Controversy has pressed India into action to tackle antibiotic resistance. Now other countries must do the same, says Priya Shetty.

A partnership involving the US Food and Drug Administration may speed up delivery of new tuberculosis drug combinations, says Priya Shetty.

Multidrug-resistant TB needs more research to equip healthcare workers with the right tools, write Frank G. J. Cobelens and colleagues.

With the worldwide growth of resistance, new antibiotics are increasingly needed. But R&D can be expensive and time-consuming, says James Love.

Reducing antibiotic use is not enough to curb the rise of resistance in the developing world, say Zulfiqar A. Bhutta and Syed Rehan Ali.

Tackling antibiotic resistance requires well-run diagnostic laboratories, says Pradeep Seth.

The best way for European countries to combat tuberculosis is to help developing countries first, say Bruce Currey and colleagues.

Controlling tuberculosis in the developing world means investing in suitably equipped labs as well as in diagnostics, argues Evelyn Harvey.